Executive Bio
Dr. Stephen R. Quake, also known as Steve, D.phil., Ph.D., co-founded Molecular Stethoscope, Inc. in 2015. Dr. Quake co-founded Fluidigm Corporation in 1999. He is Founder of Cellular Research, Inc (acquired by Becton Dickinson) and serves as its Advisor. He is Founder of Agenovir Corporation and serves as its Chairman of Scientific Advisory Board. He founded or co-founded several companies including Verinata Health (acquired by Illumina), Quanticel Pharmaceuticals (acquired by Celgene), Moleculo Cellular Research (acquired by Illumina), and ImmuMetrix (acquired by CareDx). He serves as a Co-Chairman at Department of Bioengineering of Howard Hughes Medical Institute. Dr. Quake serves as the Lee Otterson Professor of Bioengineering and Applied Physics at Stanford University. His interests lie at the nexus of physics, biology and technology, where he has made numerous contributions to the fields of microfluidics, next generation sequencing and genomic analysis. He has been an Investigator of the Howard Hughes Medical Institute since 2005. He serves as an Associate Professor in the Department of Applied Physics at the California Institute of Technology. In 1996, Dr. Quake joined the faculty of the California Institute of Technology, where he rose through the ranks and was ultimately appointed the Thomas and Doris Everhart Professor of Applied Physics and Physics. He moved back to Stanford University in 2004 to help launch a new department in Bioengineering. Dr. Quake was a Co-Founder of Helicos BioSciences Corporation. Throughout his career, he is active in the field of single molecule biophysics and has focused on precision measurements on single molecules. Previously, Dr. Quake served as a Scientific Consultant to SEQ. Prior to this, he held research positions at several esteemed institutions, including the Xerox Institute for Research on Learning and the Mathematics Department at Yale University. He serves as Chairman of Advisory Board at Fluidigm Corporation. He served as Chairman of Scientific Advisory Board at Helicos BioSciences Corporation. He serves as a Member of Scientific Advisory Board at GenapSys, Inc. He has been a Member of Advisory Board of Fluidigm Corporation since June 1999. He serves as a Member of Scientific Advisory Board at Institute for Systems Biology. He serves as a Member of Scientific Advisory Board and Member of Clinical advisory board at Verinata Health, Inc. He served as a Director of Fluidigm Corporation. Dr. Quake has published over 20 papers in the fields of microfluidics and biophysics. Dr. Quake has received many scientific awards and honors, including the opportunity to participate in the N.A.E. Symposium for Frontiers in Science in 2000 and was awarded the NSF Career award in 1997. He is the recipient of numerous international awards, including the Human Frontiers of Science Nakasone Prize, the MIT-Lemelson Prize for Innovation, the Raymond and Beverly Sackler International Prize in Biophysics, the NIH Director's Pioneer Award, the American Society of Microbiology's Promega Biotechnology Award and the Royal Society of Chemistry Publishing's Pioneer of Miniaturization Award. Dr. Quake has been elected to the National Academy of Sciences, the National Academy of Engineering, the Institute of Medicine, the American Physical Society and the American Institute for Medical and Biological Engineering. His numerous career recognitions include First award in 1997 from the National Science Foundation and National Institutes of Health and the NIH Director's Pioneer Award in 2004 with recent awards from the MIT Technology Review Magazine, Forbes and Popular Science. He was named a Packard Fellow in 1999. He spent two years as a Post-Doc in Nobel Laureate Steven Chu's group at Stanford University developing techniques to manipulate single DNA molecules with optical tweezers. Dr. Quake holds a BS in Physics and an M.S. in Mathematics from Stanford University in 1991 and a Doctorate in Physics and a Ph.D. in Theoretical Physics from Oxford University in 1994 as a Marshall scholar.